nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—ABCC2—type 2 diabetes mellitus	0.24	0.6	CbGaD
Ofloxacin—CYP1A2—type 2 diabetes mellitus	0.16	0.4	CbGaD
Ofloxacin—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0515	0.149	CbGbCtD
Ofloxacin—ABCC1—Glyburide—type 2 diabetes mellitus	0.0487	0.141	CbGbCtD
Ofloxacin—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0459	0.133	CbGbCtD
Ofloxacin—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0391	0.113	CbGbCtD
Ofloxacin—ABCC2—Glyburide—type 2 diabetes mellitus	0.036	0.104	CbGbCtD
Ofloxacin—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0264	0.0764	CbGbCtD
Ofloxacin—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0242	0.0701	CbGbCtD
Ofloxacin—SLC22A6—Losartan—type 2 diabetes mellitus	0.0241	0.0699	CbGbCtD
Ofloxacin—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0191	0.0552	CbGbCtD
Ofloxacin—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.018	0.0522	CbGbCtD
Ofloxacin—CYP1A2—Losartan—type 2 diabetes mellitus	0.0123	0.0356	CbGbCtD
Ofloxacin—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.0013	0.724	CbGdCrCtD
Ofloxacin—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000494	0.276	CbGdCrCtD
Ofloxacin—Sparfloxacin—ABCC2—type 2 diabetes mellitus	0.000476	0.151	CrCbGaD
Ofloxacin—Lomefloxacin—ABCC2—type 2 diabetes mellitus	0.000392	0.124	CrCbGaD
Ofloxacin—Pefloxacin—CYP1A2—type 2 diabetes mellitus	0.000369	0.117	CrCbGaD
Ofloxacin—Enoxacin—CYP1A2—type 2 diabetes mellitus	0.000345	0.109	CrCbGaD
Ofloxacin—Gatifloxacin—ALB—type 2 diabetes mellitus	0.000281	0.0891	CrCbGaD
Ofloxacin—Lomefloxacin—CYP1A2—type 2 diabetes mellitus	0.000262	0.0829	CrCbGaD
Ofloxacin—Levofloxacin—CYP1A2—type 2 diabetes mellitus	0.000224	0.0708	CrCbGaD
Ofloxacin—Ciprofloxacin—CYP1A2—type 2 diabetes mellitus	0.000216	0.0684	CrCbGaD
Ofloxacin—Norfloxacin—CYP1A2—type 2 diabetes mellitus	0.000181	0.0574	CrCbGaD
Ofloxacin—Levofloxacin—CYP3A4—type 2 diabetes mellitus	0.000148	0.0469	CrCbGaD
Ofloxacin—Ciprofloxacin—CYP3A4—type 2 diabetes mellitus	0.000143	0.0453	CrCbGaD
Ofloxacin—Norfloxacin—CYP3A4—type 2 diabetes mellitus	0.00012	0.038	CrCbGaD
Ofloxacin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.83e-05	0.00024	CcSEcCtD
Ofloxacin—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.83e-05	0.00024	CcSEcCtD
Ofloxacin—Vertigo—Losartan—type 2 diabetes mellitus	4.83e-05	0.00024	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.00024	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.82e-05	0.00024	CcSEcCtD
Ofloxacin—Somnolence—Valsartan—type 2 diabetes mellitus	4.82e-05	0.000239	CcSEcCtD
Ofloxacin—Syncope—Losartan—type 2 diabetes mellitus	4.82e-05	0.000239	CcSEcCtD
Ofloxacin—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.81e-05	0.000239	CcSEcCtD
Ofloxacin—Leukopenia—Losartan—type 2 diabetes mellitus	4.81e-05	0.000239	CcSEcCtD
Ofloxacin—Discomfort—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000239	CcSEcCtD
Ofloxacin—Skin disorder—Metformin—type 2 diabetes mellitus	4.8e-05	0.000238	CcSEcCtD
Ofloxacin—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000237	CcSEcCtD
Ofloxacin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.77e-05	0.000237	CcSEcCtD
Ofloxacin—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.77e-05	0.000237	CcSEcCtD
Ofloxacin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000237	CcSEcCtD
Ofloxacin—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.75e-05	0.000236	CcSEcCtD
Ofloxacin—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.75e-05	0.000236	CcSEcCtD
Ofloxacin—Palpitations—Losartan—type 2 diabetes mellitus	4.75e-05	0.000236	CcSEcCtD
Ofloxacin—Nausea—Glimepiride—type 2 diabetes mellitus	4.73e-05	0.000235	CcSEcCtD
Ofloxacin—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000235	CcSEcCtD
Ofloxacin—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.72e-05	0.000235	CcSEcCtD
Ofloxacin—Nausea—Sitagliptin—type 2 diabetes mellitus	4.72e-05	0.000234	CcSEcCtD
Ofloxacin—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.72e-05	0.000234	CcSEcCtD
Ofloxacin—Asthenia—Glyburide—type 2 diabetes mellitus	4.71e-05	0.000234	CcSEcCtD
Ofloxacin—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.71e-05	0.000234	CcSEcCtD
Ofloxacin—Anorexia—Metformin—type 2 diabetes mellitus	4.71e-05	0.000234	CcSEcCtD
Ofloxacin—Cough—Losartan—type 2 diabetes mellitus	4.69e-05	0.000233	CcSEcCtD
Ofloxacin—Urticaria—Gliclazide—type 2 diabetes mellitus	4.69e-05	0.000233	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.68e-05	0.000232	CcSEcCtD
Ofloxacin—Alopecia—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000232	CcSEcCtD
Ofloxacin—Fatigue—Valsartan—type 2 diabetes mellitus	4.67e-05	0.000232	CcSEcCtD
Ofloxacin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.66e-05	0.000232	CcSEcCtD
Ofloxacin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.66e-05	0.000232	CcSEcCtD
Ofloxacin—Oedema—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000231	CcSEcCtD
Ofloxacin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000231	CcSEcCtD
Ofloxacin—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.66e-05	0.000231	CcSEcCtD
Ofloxacin—Pruritus—Glyburide—type 2 diabetes mellitus	4.65e-05	0.000231	CcSEcCtD
Ofloxacin—Mental disorder—Ramipril—type 2 diabetes mellitus	4.64e-05	0.00023	CcSEcCtD
Ofloxacin—Constipation—Valsartan—type 2 diabetes mellitus	4.64e-05	0.00023	CcSEcCtD
Ofloxacin—Infection—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.00023	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.62e-05	0.00023	CcSEcCtD
Ofloxacin—Fatigue—Orlistat—type 2 diabetes mellitus	4.62e-05	0.000229	CcSEcCtD
Ofloxacin—Hypotension—Metformin—type 2 diabetes mellitus	4.61e-05	0.000229	CcSEcCtD
Ofloxacin—Erythema—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000229	CcSEcCtD
Ofloxacin—Malnutrition—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000229	CcSEcCtD
Ofloxacin—Shock—Irbesartan—type 2 diabetes mellitus	4.58e-05	0.000228	CcSEcCtD
Ofloxacin—Pain—Orlistat—type 2 diabetes mellitus	4.58e-05	0.000228	CcSEcCtD
Ofloxacin—Chest pain—Losartan—type 2 diabetes mellitus	4.57e-05	0.000227	CcSEcCtD
Ofloxacin—Myalgia—Losartan—type 2 diabetes mellitus	4.57e-05	0.000227	CcSEcCtD
Ofloxacin—Arthralgia—Losartan—type 2 diabetes mellitus	4.57e-05	0.000227	CcSEcCtD
Ofloxacin—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.57e-05	0.000227	CcSEcCtD
Ofloxacin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000227	CcSEcCtD
Ofloxacin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.000227	CcSEcCtD
Ofloxacin—Anxiety—Losartan—type 2 diabetes mellitus	4.56e-05	0.000226	CcSEcCtD
Ofloxacin—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.55e-05	0.000226	CcSEcCtD
Ofloxacin—Rash—Bromocriptine—type 2 diabetes mellitus	4.53e-05	0.000225	CcSEcCtD
Ofloxacin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.53e-05	0.000225	CcSEcCtD
Ofloxacin—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000225	CcSEcCtD
Ofloxacin—Tension—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000225	CcSEcCtD
Ofloxacin—Discomfort—Losartan—type 2 diabetes mellitus	4.52e-05	0.000224	CcSEcCtD
Ofloxacin—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000224	CcSEcCtD
Ofloxacin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.000224	CcSEcCtD
Ofloxacin—Headache—Bromocriptine—type 2 diabetes mellitus	4.5e-05	0.000224	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.5e-05	0.000223	CcSEcCtD
Ofloxacin—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.5e-05	0.000223	CcSEcCtD
Ofloxacin—Nervousness—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000222	CcSEcCtD
Ofloxacin—Dry mouth—Losartan—type 2 diabetes mellitus	4.47e-05	0.000222	CcSEcCtD
Ofloxacin—Anorexia—Irbesartan—type 2 diabetes mellitus	4.44e-05	0.000221	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.43e-05	0.00022	CcSEcCtD
Ofloxacin—Paraesthesia—Metformin—type 2 diabetes mellitus	4.43e-05	0.00022	CcSEcCtD
Ofloxacin—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.43e-05	0.00022	CcSEcCtD
Ofloxacin—Confusional state—Losartan—type 2 diabetes mellitus	4.42e-05	0.00022	CcSEcCtD
Ofloxacin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.41e-05	0.000219	CcSEcCtD
Ofloxacin—Dyspnoea—Metformin—type 2 diabetes mellitus	4.4e-05	0.000219	CcSEcCtD
Ofloxacin—Somnolence—Metformin—type 2 diabetes mellitus	4.39e-05	0.000218	CcSEcCtD
Ofloxacin—Oedema—Losartan—type 2 diabetes mellitus	4.38e-05	0.000218	CcSEcCtD
Ofloxacin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.38e-05	0.000218	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.38e-05	0.000218	CcSEcCtD
Ofloxacin—Infection—Losartan—type 2 diabetes mellitus	4.36e-05	0.000216	CcSEcCtD
Ofloxacin—Hypotension—Irbesartan—type 2 diabetes mellitus	4.35e-05	0.000216	CcSEcCtD
Ofloxacin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.35e-05	0.000216	CcSEcCtD
Ofloxacin—Dyspepsia—Metformin—type 2 diabetes mellitus	4.35e-05	0.000216	CcSEcCtD
Ofloxacin—Tremor—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000214	CcSEcCtD
Ofloxacin—Shock—Losartan—type 2 diabetes mellitus	4.31e-05	0.000214	CcSEcCtD
Ofloxacin—Urticaria—Valsartan—type 2 diabetes mellitus	4.31e-05	0.000214	CcSEcCtD
Ofloxacin—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.3e-05	0.000214	CcSEcCtD
Ofloxacin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.29e-05	0.000213	CcSEcCtD
Ofloxacin—Decreased appetite—Metformin—type 2 diabetes mellitus	4.29e-05	0.000213	CcSEcCtD
Ofloxacin—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.29e-05	0.000213	CcSEcCtD
Ofloxacin—Tachycardia—Losartan—type 2 diabetes mellitus	4.28e-05	0.000213	CcSEcCtD
Ofloxacin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000212	CcSEcCtD
Ofloxacin—Nausea—Bromocriptine—type 2 diabetes mellitus	4.27e-05	0.000212	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.26e-05	0.000212	CcSEcCtD
Ofloxacin—Fatigue—Metformin—type 2 diabetes mellitus	4.26e-05	0.000211	CcSEcCtD
Ofloxacin—Urticaria—Orlistat—type 2 diabetes mellitus	4.26e-05	0.000211	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.000211	CcSEcCtD
Ofloxacin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.24e-05	0.000211	CcSEcCtD
Ofloxacin—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.23e-05	0.00021	CcSEcCtD
Ofloxacin—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.23e-05	0.00021	CcSEcCtD
Ofloxacin—Asthenia—Gliclazide—type 2 diabetes mellitus	4.23e-05	0.00021	CcSEcCtD
Ofloxacin—Agitation—Ramipril—type 2 diabetes mellitus	4.23e-05	0.00021	CcSEcCtD
Ofloxacin—Constipation—Metformin—type 2 diabetes mellitus	4.22e-05	0.00021	CcSEcCtD
Ofloxacin—Angioedema—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000209	CcSEcCtD
Ofloxacin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.18e-05	0.000208	CcSEcCtD
Ofloxacin—Anorexia—Losartan—type 2 diabetes mellitus	4.18e-05	0.000208	CcSEcCtD
Ofloxacin—Vomiting—Glyburide—type 2 diabetes mellitus	4.18e-05	0.000208	CcSEcCtD
Ofloxacin—Pruritus—Gliclazide—type 2 diabetes mellitus	4.17e-05	0.000207	CcSEcCtD
Ofloxacin—Malaise—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000206	CcSEcCtD
Ofloxacin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000206	CcSEcCtD
Ofloxacin—Rash—Glyburide—type 2 diabetes mellitus	4.14e-05	0.000206	CcSEcCtD
Ofloxacin—Somnolence—Irbesartan—type 2 diabetes mellitus	4.14e-05	0.000206	CcSEcCtD
Ofloxacin—Dermatitis—Glyburide—type 2 diabetes mellitus	4.14e-05	0.000206	CcSEcCtD
Ofloxacin—Vertigo—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000206	CcSEcCtD
Ofloxacin—Syncope—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000205	CcSEcCtD
Ofloxacin—Leukopenia—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000205	CcSEcCtD
Ofloxacin—Headache—Glyburide—type 2 diabetes mellitus	4.12e-05	0.000204	CcSEcCtD
Ofloxacin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.1e-05	0.000204	CcSEcCtD
Ofloxacin—Hypotension—Losartan—type 2 diabetes mellitus	4.1e-05	0.000204	CcSEcCtD
Ofloxacin—Palpitations—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000202	CcSEcCtD
Ofloxacin—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.07e-05	0.000202	CcSEcCtD
Ofloxacin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000201	CcSEcCtD
Ofloxacin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000201	CcSEcCtD
Ofloxacin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.04e-05	0.000201	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.04e-05	0.000201	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.0002	CcSEcCtD
Ofloxacin—Cough—Ramipril—type 2 diabetes mellitus	4.02e-05	0.0002	CcSEcCtD
Ofloxacin—Fatigue—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.0002	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.99e-05	0.000198	CcSEcCtD
Ofloxacin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.99e-05	0.000198	CcSEcCtD
Ofloxacin—Pain—Irbesartan—type 2 diabetes mellitus	3.98e-05	0.000198	CcSEcCtD
Ofloxacin—Constipation—Irbesartan—type 2 diabetes mellitus	3.98e-05	0.000198	CcSEcCtD
Ofloxacin—Insomnia—Losartan—type 2 diabetes mellitus	3.97e-05	0.000197	CcSEcCtD
Ofloxacin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.95e-05	0.000196	CcSEcCtD
Ofloxacin—Paraesthesia—Losartan—type 2 diabetes mellitus	3.94e-05	0.000196	CcSEcCtD
Ofloxacin—Urticaria—Metformin—type 2 diabetes mellitus	3.92e-05	0.000195	CcSEcCtD
Ofloxacin—Arthralgia—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000195	CcSEcCtD
Ofloxacin—Chest pain—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000195	CcSEcCtD
Ofloxacin—Myalgia—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000195	CcSEcCtD
Ofloxacin—Dyspnoea—Losartan—type 2 diabetes mellitus	3.91e-05	0.000194	CcSEcCtD
Ofloxacin—Anxiety—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000194	CcSEcCtD
Ofloxacin—Nausea—Glyburide—type 2 diabetes mellitus	3.9e-05	0.000194	CcSEcCtD
Ofloxacin—Abdominal pain—Metformin—type 2 diabetes mellitus	3.9e-05	0.000194	CcSEcCtD
Ofloxacin—Dizziness—Gliclazide—type 2 diabetes mellitus	3.9e-05	0.000194	CcSEcCtD
Ofloxacin—Somnolence—Losartan—type 2 diabetes mellitus	3.9e-05	0.000194	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000193	CcSEcCtD
Ofloxacin—Asthenia—Valsartan—type 2 diabetes mellitus	3.89e-05	0.000193	CcSEcCtD
Ofloxacin—Discomfort—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000192	CcSEcCtD
Ofloxacin—Dyspepsia—Losartan—type 2 diabetes mellitus	3.86e-05	0.000192	CcSEcCtD
Ofloxacin—Asthenia—Orlistat—type 2 diabetes mellitus	3.84e-05	0.000191	CcSEcCtD
Ofloxacin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.84e-05	0.000191	CcSEcCtD
Ofloxacin—Pruritus—Valsartan—type 2 diabetes mellitus	3.84e-05	0.000191	CcSEcCtD
Ofloxacin—Dry mouth—Ramipril—type 2 diabetes mellitus	3.84e-05	0.000191	CcSEcCtD
Ofloxacin—Decreased appetite—Losartan—type 2 diabetes mellitus	3.81e-05	0.000189	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.81e-05	0.000189	CcSEcCtD
Ofloxacin—Confusional state—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000188	CcSEcCtD
Ofloxacin—Pruritus—Orlistat—type 2 diabetes mellitus	3.79e-05	0.000188	CcSEcCtD
Ofloxacin—Fatigue—Losartan—type 2 diabetes mellitus	3.78e-05	0.000188	CcSEcCtD
Ofloxacin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000187	CcSEcCtD
Ofloxacin—Oedema—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000187	CcSEcCtD
Ofloxacin—Vomiting—Gliclazide—type 2 diabetes mellitus	3.75e-05	0.000186	CcSEcCtD
Ofloxacin—Pain—Losartan—type 2 diabetes mellitus	3.75e-05	0.000186	CcSEcCtD
Ofloxacin—Constipation—Losartan—type 2 diabetes mellitus	3.75e-05	0.000186	CcSEcCtD
Ofloxacin—Rash—Gliclazide—type 2 diabetes mellitus	3.72e-05	0.000185	CcSEcCtD
Ofloxacin—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.72e-05	0.000185	CcSEcCtD
Ofloxacin—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.71e-05	0.000184	CcSEcCtD
Ofloxacin—Urticaria—Irbesartan—type 2 diabetes mellitus	3.7e-05	0.000184	CcSEcCtD
Ofloxacin—Shock—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000184	CcSEcCtD
Ofloxacin—Headache—Gliclazide—type 2 diabetes mellitus	3.7e-05	0.000184	CcSEcCtD
Ofloxacin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000183	CcSEcCtD
Ofloxacin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.68e-05	0.000183	CcSEcCtD
Ofloxacin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.68e-05	0.000183	CcSEcCtD
Ofloxacin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000183	CcSEcCtD
Ofloxacin—Tachycardia—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000182	CcSEcCtD
Ofloxacin—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.67e-05	0.000182	CcSEcCtD
Ofloxacin—Skin disorder—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000181	CcSEcCtD
Ofloxacin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000181	CcSEcCtD
Ofloxacin—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.61e-05	0.000179	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.59e-05	0.000178	CcSEcCtD
Ofloxacin—Dizziness—Valsartan—type 2 diabetes mellitus	3.58e-05	0.000178	CcSEcCtD
Ofloxacin—Anorexia—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000178	CcSEcCtD
Ofloxacin—Dizziness—Orlistat—type 2 diabetes mellitus	3.54e-05	0.000176	CcSEcCtD
Ofloxacin—Asthenia—Metformin—type 2 diabetes mellitus	3.54e-05	0.000176	CcSEcCtD
Ofloxacin—Hypotension—Ramipril—type 2 diabetes mellitus	3.51e-05	0.000174	CcSEcCtD
Ofloxacin—Nausea—Gliclazide—type 2 diabetes mellitus	3.5e-05	0.000174	CcSEcCtD
Ofloxacin—Pruritus—Metformin—type 2 diabetes mellitus	3.49e-05	0.000173	CcSEcCtD
Ofloxacin—Urticaria—Losartan—type 2 diabetes mellitus	3.48e-05	0.000173	CcSEcCtD
Ofloxacin—Body temperature increased—Losartan—type 2 diabetes mellitus	3.47e-05	0.000172	CcSEcCtD
Ofloxacin—Abdominal pain—Losartan—type 2 diabetes mellitus	3.47e-05	0.000172	CcSEcCtD
Ofloxacin—Vomiting—Valsartan—type 2 diabetes mellitus	3.45e-05	0.000171	CcSEcCtD
Ofloxacin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.00017	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.43e-05	0.00017	CcSEcCtD
Ofloxacin—Rash—Valsartan—type 2 diabetes mellitus	3.42e-05	0.00017	CcSEcCtD
Ofloxacin—Dermatitis—Valsartan—type 2 diabetes mellitus	3.41e-05	0.00017	CcSEcCtD
Ofloxacin—Vomiting—Orlistat—type 2 diabetes mellitus	3.41e-05	0.000169	CcSEcCtD
Ofloxacin—Insomnia—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000169	CcSEcCtD
Ofloxacin—Headache—Valsartan—type 2 diabetes mellitus	3.4e-05	0.000169	CcSEcCtD
Ofloxacin—Diarrhoea—Metformin—type 2 diabetes mellitus	3.38e-05	0.000168	CcSEcCtD
Ofloxacin—Rash—Orlistat—type 2 diabetes mellitus	3.38e-05	0.000168	CcSEcCtD
Ofloxacin—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000168	CcSEcCtD
Ofloxacin—Dermatitis—Orlistat—type 2 diabetes mellitus	3.37e-05	0.000168	CcSEcCtD
Ofloxacin—Headache—Orlistat—type 2 diabetes mellitus	3.36e-05	0.000167	CcSEcCtD
Ofloxacin—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000166	CcSEcCtD
Ofloxacin—Asthenia—Irbesartan—type 2 diabetes mellitus	3.34e-05	0.000166	CcSEcCtD
Ofloxacin—Somnolence—Ramipril—type 2 diabetes mellitus	3.34e-05	0.000166	CcSEcCtD
Ofloxacin—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000164	CcSEcCtD
Ofloxacin—Pruritus—Irbesartan—type 2 diabetes mellitus	3.3e-05	0.000164	CcSEcCtD
Ofloxacin—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000162	CcSEcCtD
Ofloxacin—Dizziness—Metformin—type 2 diabetes mellitus	3.26e-05	0.000162	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000161	CcSEcCtD
Ofloxacin—Fatigue—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000161	CcSEcCtD
Ofloxacin—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.23e-05	0.00016	CcSEcCtD
Ofloxacin—Nausea—Valsartan—type 2 diabetes mellitus	3.22e-05	0.00016	CcSEcCtD
Ofloxacin—Constipation—Ramipril—type 2 diabetes mellitus	3.21e-05	0.00016	CcSEcCtD
Ofloxacin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.000158	CcSEcCtD
Ofloxacin—Nausea—Orlistat—type 2 diabetes mellitus	3.18e-05	0.000158	CcSEcCtD
Ofloxacin—Asthenia—Losartan—type 2 diabetes mellitus	3.15e-05	0.000156	CcSEcCtD
Ofloxacin—Vomiting—Metformin—type 2 diabetes mellitus	3.14e-05	0.000156	CcSEcCtD
Ofloxacin—Rash—Metformin—type 2 diabetes mellitus	3.11e-05	0.000155	CcSEcCtD
Ofloxacin—Dermatitis—Metformin—type 2 diabetes mellitus	3.11e-05	0.000154	CcSEcCtD
Ofloxacin—Pruritus—Losartan—type 2 diabetes mellitus	3.1e-05	0.000154	CcSEcCtD
Ofloxacin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000154	CcSEcCtD
Ofloxacin—Headache—Metformin—type 2 diabetes mellitus	3.09e-05	0.000154	CcSEcCtD
Ofloxacin—Dizziness—Irbesartan—type 2 diabetes mellitus	3.08e-05	0.000153	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000153	CcSEcCtD
Ofloxacin—Diarrhoea—Losartan—type 2 diabetes mellitus	3e-05	0.000149	CcSEcCtD
Ofloxacin—Urticaria—Ramipril—type 2 diabetes mellitus	2.99e-05	0.000148	CcSEcCtD
Ofloxacin—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000148	CcSEcCtD
Ofloxacin—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000148	CcSEcCtD
Ofloxacin—Vomiting—Irbesartan—type 2 diabetes mellitus	2.96e-05	0.000147	CcSEcCtD
Ofloxacin—Rash—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000146	CcSEcCtD
Ofloxacin—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.93e-05	0.000146	CcSEcCtD
Ofloxacin—Nausea—Metformin—type 2 diabetes mellitus	2.93e-05	0.000146	CcSEcCtD
Ofloxacin—Headache—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000145	CcSEcCtD
Ofloxacin—Dizziness—Losartan—type 2 diabetes mellitus	2.9e-05	0.000144	CcSEcCtD
Ofloxacin—Vomiting—Losartan—type 2 diabetes mellitus	2.79e-05	0.000138	CcSEcCtD
Ofloxacin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.77e-05	0.000138	CcSEcCtD
Ofloxacin—Nausea—Irbesartan—type 2 diabetes mellitus	2.77e-05	0.000137	CcSEcCtD
Ofloxacin—Rash—Losartan—type 2 diabetes mellitus	2.76e-05	0.000137	CcSEcCtD
Ofloxacin—Dermatitis—Losartan—type 2 diabetes mellitus	2.76e-05	0.000137	CcSEcCtD
Ofloxacin—Headache—Losartan—type 2 diabetes mellitus	2.75e-05	0.000136	CcSEcCtD
Ofloxacin—Asthenia—Ramipril—type 2 diabetes mellitus	2.7e-05	0.000134	CcSEcCtD
Ofloxacin—Pruritus—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000132	CcSEcCtD
Ofloxacin—Nausea—Losartan—type 2 diabetes mellitus	2.6e-05	0.000129	CcSEcCtD
Ofloxacin—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000128	CcSEcCtD
Ofloxacin—Dizziness—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000123	CcSEcCtD
Ofloxacin—Vomiting—Ramipril—type 2 diabetes mellitus	2.39e-05	0.000119	CcSEcCtD
Ofloxacin—Rash—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000118	CcSEcCtD
Ofloxacin—Dermatitis—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000118	CcSEcCtD
Ofloxacin—Headache—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000117	CcSEcCtD
Ofloxacin—Nausea—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000111	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—UCP2—type 2 diabetes mellitus	2.21e-05	0.00046	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—UCP3—type 2 diabetes mellitus	2.21e-05	0.00046	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HSD11B1—type 2 diabetes mellitus	2.21e-05	0.00046	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.2e-05	0.000458	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.16e-05	0.00045	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.15e-05	0.000448	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ALDOB—type 2 diabetes mellitus	2.15e-05	0.000448	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.15e-05	0.000446	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.14e-05	0.000445	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.14e-05	0.000444	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.13e-05	0.000443	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.13e-05	0.000443	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—type 2 diabetes mellitus	2.13e-05	0.000443	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	2.12e-05	0.00044	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	2.12e-05	0.00044	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	2.12e-05	0.00044	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.11e-05	0.000439	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	2.11e-05	0.000438	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PCK1—type 2 diabetes mellitus	2.08e-05	0.000432	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.06e-05	0.000429	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.06e-05	0.000429	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SPRY2—type 2 diabetes mellitus	2.05e-05	0.000427	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.05e-05	0.000426	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.05e-05	0.000425	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.04e-05	0.000424	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.04e-05	0.000423	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RBP4—type 2 diabetes mellitus	2e-05	0.000416	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2e-05	0.000415	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.99e-05	0.000414	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HK1—type 2 diabetes mellitus	1.95e-05	0.000405	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.95e-05	0.000405	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.93e-05	0.000401	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	1.92e-05	0.000399	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.91e-05	0.000396	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	1.89e-05	0.000392	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2A—type 2 diabetes mellitus	1.88e-05	0.000392	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.88e-05	0.000391	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GCKR—type 2 diabetes mellitus	1.88e-05	0.000391	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LPA—type 2 diabetes mellitus	1.88e-05	0.000391	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.88e-05	0.000391	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC2A2—type 2 diabetes mellitus	1.87e-05	0.000389	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTR—type 2 diabetes mellitus	1.83e-05	0.000381	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.81e-05	0.000376	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALDOB—type 2 diabetes mellitus	1.8e-05	0.000375	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.8e-05	0.000374	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NAMPT—type 2 diabetes mellitus	1.8e-05	0.000373	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—GCK—type 2 diabetes mellitus	1.78e-05	0.000371	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IAPP—type 2 diabetes mellitus	1.77e-05	0.000369	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.77e-05	0.000368	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.75e-05	0.000364	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC9A1—type 2 diabetes mellitus	1.74e-05	0.000362	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.74e-05	0.000362	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.72e-05	0.000358	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.72e-05	0.000357	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.7e-05	0.000353	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.69e-05	0.00035	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GLP1R—type 2 diabetes mellitus	1.68e-05	0.000349	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.63e-05	0.000339	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HMGA1—type 2 diabetes mellitus	1.63e-05	0.000339	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.61e-05	0.000335	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	1.6e-05	0.000334	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	1.6e-05	0.000334	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PSMD6—type 2 diabetes mellitus	1.6e-05	0.000333	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SNAP25—type 2 diabetes mellitus	1.6e-05	0.000333	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	1.57e-05	0.000327	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.57e-05	0.000325	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CYBA—type 2 diabetes mellitus	1.55e-05	0.000322	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MTR—type 2 diabetes mellitus	1.53e-05	0.000319	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CPT1A—type 2 diabetes mellitus	1.53e-05	0.000319	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NAMPT—type 2 diabetes mellitus	1.5e-05	0.000313	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CALCA—type 2 diabetes mellitus	1.5e-05	0.000312	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.5e-05	0.000311	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GCK—type 2 diabetes mellitus	1.49e-05	0.000311	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HBA1—type 2 diabetes mellitus	1.49e-05	0.000311	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LIPC—type 2 diabetes mellitus	1.49e-05	0.000311	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.49e-05	0.000309	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.46e-05	0.000303	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC2A1—type 2 diabetes mellitus	1.45e-05	0.000301	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CETP—type 2 diabetes mellitus	1.44e-05	0.0003	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS1—type 2 diabetes mellitus	1.43e-05	0.000297	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TCF7L2—type 2 diabetes mellitus	1.41e-05	0.000293	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC2A4—type 2 diabetes mellitus	1.39e-05	0.000289	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	1.38e-05	0.000286	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.38e-05	0.000286	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.34e-05	0.00028	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PSMD6—type 2 diabetes mellitus	1.34e-05	0.000279	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SREBF1—type 2 diabetes mellitus	1.34e-05	0.000279	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SNAP25—type 2 diabetes mellitus	1.34e-05	0.000279	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.34e-05	0.000278	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CTGF—type 2 diabetes mellitus	1.32e-05	0.000274	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.31e-05	0.000272	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HMGCR—type 2 diabetes mellitus	1.3e-05	0.000271	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.3e-05	0.000271	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.3e-05	0.000271	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.29e-05	0.000269	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.29e-05	0.000267	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.28e-05	0.000266	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.28e-05	0.000265	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.27e-05	0.000265	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.27e-05	0.000263	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.24e-05	0.000259	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.23e-05	0.000256	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.23e-05	0.000255	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.21e-05	0.000252	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.21e-05	0.000252	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFBR2—type 2 diabetes mellitus	1.21e-05	0.000251	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.18e-05	0.000246	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.18e-05	0.000245	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN2B—type 2 diabetes mellitus	1.17e-05	0.000243	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.16e-05	0.000242	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GCG—type 2 diabetes mellitus	1.16e-05	0.000242	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.15e-05	0.000239	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.15e-05	0.000239	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.14e-05	0.000238	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOB—type 2 diabetes mellitus	1.14e-05	0.000237	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.12e-05	0.000233	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.11e-05	0.000231	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	1.11e-05	0.000231	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.11e-05	0.000231	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	1.11e-05	0.000231	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	1.11e-05	0.000231	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	1.11e-05	0.000231	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—LPL—type 2 diabetes mellitus	1.09e-05	0.000226	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.07e-05	0.000223	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ADCY5—type 2 diabetes mellitus	1.07e-05	0.000222	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PPP2CA—type 2 diabetes mellitus	1.02e-05	0.000212	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.01e-05	0.000211	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.01e-05	0.000211	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CCR5—type 2 diabetes mellitus	1e-05	0.000209	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1e-05	0.000208	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GNB3—type 2 diabetes mellitus	1e-05	0.000208	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HMOX1—type 2 diabetes mellitus	9.97e-06	0.000207	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	9.88e-06	0.000205	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CAT—type 2 diabetes mellitus	9.84e-06	0.000205	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTHFR—type 2 diabetes mellitus	9.81e-06	0.000204	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOB—type 2 diabetes mellitus	9.55e-06	0.000199	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	9.43e-06	0.000196	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	9.43e-06	0.000196	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	9.43e-06	0.000196	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HIF1A—type 2 diabetes mellitus	9.35e-06	0.000194	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IRS2—type 2 diabetes mellitus	9.33e-06	0.000194	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTM1—type 2 diabetes mellitus	9.29e-06	0.000193	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CALM1—type 2 diabetes mellitus	9.16e-06	0.00019	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOE—type 2 diabetes mellitus	9.13e-06	0.00019	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LPL—type 2 diabetes mellitus	9.12e-06	0.00019	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	9.04e-06	0.000188	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	9.04e-06	0.000188	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOA1—type 2 diabetes mellitus	9.03e-06	0.000188	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ADCY5—type 2 diabetes mellitus	8.93e-06	0.000186	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GPX1—type 2 diabetes mellitus	8.9e-06	0.000185	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	8.7e-06	0.000181	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	8.7e-06	0.000181	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CD36—type 2 diabetes mellitus	8.67e-06	0.00018	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPP2CA—type 2 diabetes mellitus	8.56e-06	0.000178	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	8.55e-06	0.000178	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	8.54e-06	0.000178	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS2—type 2 diabetes mellitus	8.51e-06	0.000177	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	8.4e-06	0.000175	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	8.4e-06	0.000175	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	8.4e-06	0.000175	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MTHFR—type 2 diabetes mellitus	8.21e-06	0.000171	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	8.15e-06	0.000169	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IRS1—type 2 diabetes mellitus	8.14e-06	0.000169	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARA—type 2 diabetes mellitus	8.06e-06	0.000167	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	7.9e-06	0.000164	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AGT—type 2 diabetes mellitus	7.8e-06	0.000162	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—INS—type 2 diabetes mellitus	7.8e-06	0.000162	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.78e-06	0.000162	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CALM1—type 2 diabetes mellitus	7.67e-06	0.00016	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOE—type 2 diabetes mellitus	7.65e-06	0.000159	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.59e-06	0.000158	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOA1—type 2 diabetes mellitus	7.56e-06	0.000157	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT2—type 2 diabetes mellitus	7.54e-06	0.000157	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	7.4e-06	0.000154	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.39e-06	0.000154	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	7.16e-06	0.000149	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	7.15e-06	0.000149	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	7.15e-06	0.000149	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	7.15e-06	0.000149	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	7.15e-06	0.000149	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.87e-06	0.000143	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	6.85e-06	0.000142	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	6.84e-06	0.000142	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS3—type 2 diabetes mellitus	6.84e-06	0.000142	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	6.66e-06	0.000138	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.66e-06	0.000138	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—INS—type 2 diabetes mellitus	6.53e-06	0.000136	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.52e-06	0.000136	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.45e-06	0.000134	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.37e-06	0.000132	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	6.26e-06	0.00013	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	5.99e-06	0.000124	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.95e-06	0.000124	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.83e-06	0.000121	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.83e-06	0.000121	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	5.73e-06	0.000119	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.73e-06	0.000119	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.71e-06	0.000119	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.68e-06	0.000118	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.68e-06	0.000118	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.68e-06	0.000118	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.68e-06	0.000118	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.64e-06	0.000117	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.54e-06	0.000115	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.48e-06	0.000114	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	5.24e-06	0.000109	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.11e-06	0.000106	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.09e-06	0.000106	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.09e-06	0.000106	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.09e-06	0.000106	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SRC—type 2 diabetes mellitus	5.06e-06	0.000105	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5e-06	0.000104	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.95e-06	0.000103	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.89e-06	0.000102	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.85e-06	0.000101	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.66e-06	9.68e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.61e-06	9.57e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	4.52e-06	9.4e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.49e-06	9.33e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.47e-06	9.29e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGFR—type 2 diabetes mellitus	4.43e-06	9.22e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.41e-06	9.18e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.41e-06	9.18e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.81e-06	7.91e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.81e-06	7.91e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.79e-06	7.87e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.74e-06	7.77e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.63e-06	7.54e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.53e-06	7.34e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.46e-06	7.2e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—type 2 diabetes mellitus	3.41e-06	7.08e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.39e-06	7.05e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.38e-06	7.03e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.29e-06	6.84e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.25e-06	6.76e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—type 2 diabetes mellitus	3.14e-06	6.54e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.12e-06	6.48e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.06e-06	6.36e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.96e-06	6.16e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.91e-06	6.06e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.9e-06	6.04e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.87e-06	5.97e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	2.63e-06	5.47e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-06	5.26e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	5.16e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.27e-06	4.73e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.18e-06	4.52e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.18e-06	4.52e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	4.14e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	2.08e-05	CbGpPWpGaD
